Fig. 1From: Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancerFlow chart of the study population. ICM, immune checkpoint monoclonal antibody; VA, Viscum album L., n, number of patientsBack to article page